Human papillomavirus type 6b (HPV-6b) is one of the most common causes of human genital warts, an important sexually transmitted disease. Discovery of antiviral therapies for this condition has been hampered by the inability to propagate the virus using standard tissue culture techniques and through difficulties in expressing sufficient recombinant viral proteins in vitro. Replication of papilIomavirus DNA requires two viral proteins, E1 and E2. In an effort to establish assays to discover compounds active against this virus, we have coexpressed HPV-6b E1 and E2 proteins in insect cells. We demonstrate that the two proteins form a heteromeric complex which can be purified by sequence-specific DNA affinity chromatography. We also demonstrate that the complex has both Elassociated ATPase and ATP-dependent DNA hellcase activity and report further characterization of these functions.
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Human papillomaviruses (HPVs) are non-enveloped DNA viruses which induce hyperproliferative lesions of cutaneous and mucosal epithelia (warts). Of the 100 different virus types so far identified, HPV types 6 and 11 (HPV-6 and HPV-II) are most commonly associated with benign, external genital warts or condyloma accuminata. There are currently no effective antiviral treatments for HPV infection.
Numerous studies (reviewed in have demonstrated that the viral proteins E1 and E2 are necessary and sufficient for viral DNA replication. Most of our knowledge of HPV E1 comes from work with the closely related bovine papillomavirus type I (BPV-I) protein; however, as E1 is the most highly conserved protein in papillomaAuthor for correspondence: Owen Jenkins.
Fax +44 1737 364 073, e-mail OWEN_IENKINS@SBPHRD.COM viruses its enzymatic activities are presumed to be similar for all papillomavirus types. In support of this, studies have demonstrated that E1 and E2 from heterologous virus types are capable of replicating DNA containing any papillomavirus origin of replication (Chiang et al., 1992; Del Vecchio e¢ a] ., 1992).
BPV-1 E1 is a 68 kDa DNA binding phosphoprotein with helicase and ATPase activities (Sun et at., I990; Blitz & Laimins, 1991; Wilson & Ludes-Meyers, 1991; Seo et aI., 1993a; Yang et al., 1993) . It binds specifically to the origin of replication (Ustav & Stenlund, I991; Ustav et al., I991; Meyers, 1991) but can also bind DNA non-specifically at high concentrations (Yang eta] ., 199I).
Much less is known about the biochemical properties of the E1 protein from HPVs. Immunoprecipitated HPV-11 EI expressed from recombinant baculovirus has been shown to possess ATPase and GTPase activity and to form a heteromeric complex with the E2 transcriptional transactivator protein when co-expressed in insect ceils (Bream el aI., 1993) , similar to the BPV-1 E1 protein (Mohr eta] ., 1990; Blitz & Laimins, 1991; Lu et al., 1993) . However, Bream eta] . were unable to demonstrate helicase activity from their crude preparations of HPV-11 EI.
El/E2 complex formation is essential for viral DNA replication in vivo for most HPV types (except HPV-la; Gopalakrishnan & Khan, 1994) and is thought to stabilise the interaction of E1 with its binding site and stimulate ori unwinding (Yang eta] ., 1991; Seo et a]., 1993b; Lusky et al., 1993 Lusky et al., , 1994 .
It is clear that the function of E1 and E2 is absolutely essential to the life-cycle of HPV and that it offers a unique opportunity to target chemotherapeutic intervention to its ATPase, helicase or El/E2 interaction sites. Whilst we had previously established a reporter assay based on replication of the BPV-I genome in murine cells (May et al., 1991) it is clear that there are some significant differences between BPV and HPV. Thus, in any therapeutic agent screening strategy, the use of HPV-specific assays is at least desirable, if not mandatory. However, one of the major problems has been the expression and purification of sufficient material with which to develop and run such screens. Therefore, to further characterize the E1 and E2 proteins of an HPV and to generate reagents to establish cell-free screens for the identification of inhibitors of their function, we initiated a study to express and purify E1 and E2 from the virus most commonly associated with genital condyloma, HPV-6b. The E1 and E2 genes were isolated from a full-length clone of HPV-6b, subcloned into standard baculovirus expression vectors and expressed in insect cells. Conventional sizeexclusion, ion-exchange and non-sequence-specific DNA affinity chromatography techniques were ineffective at removing contaminating host cell and baculovirus encoded nucleases and ATPase/helicases, which interfered with El-specific ATPase and helicase assays. Since it was known that E2 could be purified using an immobilized concatemerized E2 binding site DNA (Mohr et al., I990) , we surmised that a synthetic portion of the HPV ori containing the E1 binding site and multiple E2 binding sites may facilitate the purification of E1 and E2 simultaneously. E2 binding sites were included in anticipation of E2 promoting the association of E1 protein to its DNA binding site, an interaction that would probably be too weak in the absence of E2. A relatively simple batch-wise purification scheme incorporating annealed complementary 60-mer oligonucleotides (representing nucleotides 7892-49 of the HPV-6b ori), immobilized via a 5'-biotin moiety to Streptavidinagarose was shown to remove over 97% of contaminating cellular proteins as determined by protein quantification using BCA protein assay reagent (Pierce) and by silver staining of nuclear extracts before and after affinity purification (Fig. I) . Although numerous host proteins still remained in the extract after affinity purification, most importantly, the purified preparation was free from host cell and baculovirus derived nucleases and DNA helicases.
The presence of the E1 protein was demonstrated in both the crude insect cell nuclear extract and purified samples by Western blotting with antibody raised to an El-specific peptide (Fig. 1) . The presence of E2 in the nuclear extracts was demonstrated by the ability to band-shift a radioactive oligonucleotide representing an E2 binding site (data not shown).
An immunoprecipitation DNA binding assay confirmed that the HPV-6b E1 and E2 proteins formed a complex when co-expressed in insect cells in a similar fashion to the homologous HPV-11 proteins (Bream eta] ., 1993) (data not shown). A recent report has described both ATPase and DNA helicase activity of the HPV-6b protein expressed as a maltose binding protein fusion in E. coil (Hughes & Romanos, 1993) ; therefore, we examined whether our affinity purified EI/E2 preparation had similar activities and further characterized these functions. The ATPase activity of the extracts purified from insect cell nuclei was detected either by the release of [a~p]phosphate from [y-a2p]ATP by thin-layer chromatography, or quantitatively by measuring in a scintillation counter the amount of free radiolabelled organic phosphate remaining after charcoal precipitation of ADP and non-hydrolysed ATP (Clark et al., 1981) . ATPase activity could only be detected in the El/E2 infected extract. This activity showed no stimulation in the presence of a range of nucleic acids (dsDNA, ssDNA, activated DNA, 60-met oligonucleotide, 25-mer annealed to M13 ssDNA) (data not shown). This is in agreement with a very thorough study on the activity of the BPV-1 E1 protein (Santucci et al., 1995) . These authors report that the ATPase activity of BPV-1 E1 expressed in insect cells was not dependent upon binding to DNA and in general was not stimulated by a range of nucleic acids. The exception was M13 ssDNA, where marginal stimulation of ATPase activity (l'5-Y0-fold) was demonstrated in its presence. These results and ours are contrary to a previous report stating that BPV-1 E1 ATPase activity was absolutely DNA dependent (Seo et al., 1993a) . The reasons for this discrepancy are not clear. One possibility is that some DNA may have co-purified with our 80( EI/E2 complex, which accounts for the apparent DNA independence; however, using a very sensitive detection technique, Santucci et al. (1995) found only small RNA contaminants (at < 0"05 pmol 5' ends/pmol GST-E1 protein) in their bacterially produced E1 preparation which still exhibited ATPase activity. We also believe it is highly unlikely, following the very rigorous purification procedure, that nucleic acids are present in our El/E2 preparations. The ATPase activity of HPV-6h E1 when purified as an El/E2 complex was stable after multiple freeze-thaw cycles, unlike BPV E1 expressed alone which was considered to be inherently unstable by Santucci eta] . (1995) and rapidly lost its replication activity after a second chromatographic purification step. Interestingly, these authors also found that the ATPase activity of bacterially produced E1 (expressed as a GST fusion protein) was very unstable after factor Xa cleavage. It is likely that the host proteins which co-purify with our El/E2 complex help to maintain its stability. The purification of relatively large amounts of stable HPV-6b E1 has allowed for the first time a more detailed characterization of ATP hydrolysis. The results are shown in Fig. 2 . Excellent assay reproducibility was achieved using a microtitre format with a signal to noise ratio of approximately 10:1. An apparent mean K m (ATP) value of 230 ~tM was calculated for E1 using this assay system. This is the first time that an apparent K m value for an HPV E1 ATPase has been reported• The affinity of HPV E1 for ATP is therefore within the range of other helicase associated ATPases; K m values calculated for BPV-1 E1 have varied between 200 ,M (Yang et al., 1993) , 750 ~tM (Santucci et al., 1995) and 1"1 mM (MacPherson et al., 1994) . The K m value for SV40 large T ATPase activity has been reported to be 5 p,M, with a very low turn-over number comparable with BPV-1 E1 (0"03 s 1 and 0-05 s -1 respectively; Santucci et al., 1995) . Our inability to detect ATP hydrolysis by HPV-6b E1 using the rapid acidic ammonium molybdate/malachite green colorimetric assay, despite it being sensitive enough for other helicase-associated ATPases (Earnshaw & Jarvest, 1994) , would support the idea that HPV-6b E1 also exhibits a very low ATP turn-over rate. Nuclear extract from cells infected with a mutant E1 baculovirus, P479S (proline residue 479 contained within the ATP-binding domain of E1 mutated to a serine; Hughes & Romanos, 1993; Sun et aI., 1990) had no ATPase activity and bound 10-fold lower amounts of ATP (data not shown), confirming that the observed ATPase activity is associated with El.
To investigate the DNA helicase activity of the purified EI/E2 complex, DNA unwinding was monitored by the release of a 3~P-labelled 22-met from Mi3mp18 ssDNA, which was then separated by non-denaturing PAGE. Helicase activity was dependent on the presence of ATP, sensitive to increasing salt concentrations and required divalent metal cations (magnesium or manganese) (data not shown)• The processivity of E1 was examined by testing the ability of the purified El/E2 extract to unwind oligonudeotides of increasing length (Fig. 3) . Oligos of 25, 33 and 103 nucleotides were completely unwound under the assay conditions used. Initially, with a view to demonstrating sequence-specific DNA unwinding, the 103-mer oligo was annealed to M13 ssDNA containing HPV ori sequences, to create a double-stranded minimal ori region (nucleotides 7801-61). This template contained three E2 binding sites and an E1 binding site in their native positions in the ori. It was postulated that the oligo would be more efficiently unwound than non-ori templates due to increased affinity of the El/E2 complex for DNA via E2 recognizing its binding motifs. Under the conditions used, however, we were unable to demonstrate sequence-specific DNA unwinding by El/E2 and the complex unwound a 10d-iner non-ori oligo as efficiently as those containing E2 binding motifs• This is possibly due to the requirement for a large amount of E1 in the assay to detect DNA unwinding. If the assay could be run with the low levels of E1 encountered in vivo then it may be that the dependence on ori sequences would be demonstrated. Recently, Kuo et aI. (1994) extract using purified HPV-11 E1 and E2 proteins expressed in baculovirus. They also demonstrated that ori independent replication occurred at high concentrations of E1 but was suppressed by addition of E2.
The ability to express and purify stable, active El/E2 complex in sufficient amounts has enabled us to establish a microtitre plate high throughput screen based on the ATPase activity of E1 to discover and further characterize specific inhibitors of HPV replication. Unfortunately, attempts to format a high throughput helicase assay were unsuccessful, due in part to the difficulty in releasing unwound oligo from the protein complex. Targeting proteins essential for replication provides a unique opportunity not only to inhibit early stages of the virus life cycle, but also to completely eradicate viral D N A from infected keratinocytes as they differentiate and are eventually sloughed off from the surface of the skin. The high degree of conservation of the replication proteins in all the HPV types may mean that a compound active against El/E2 of one type may also be active against all types, giving hope of treatment for a range of HPV induced diseases.
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